524 related articles for article (PubMed ID: 35381762)
21. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation.
Gandhi P; Prasad UC
Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study.
Shah SN; Manjunatha BS; Shah VS; Dagrus K; Soni N; Shah S
Recent Pat Anticancer Drug Discov; 2015; 10(2):233-8. PubMed ID: 25782917
[TBL] [Abstract][Full Text] [Related]
23. Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.
Gadbail AR; Chaudhary MS; Sarode SC; Gondivkar SM; Belekar L; Mankar-Gadbail MP; Dande R; Tekade SA; Yuwanati MB; Patil S
J Investig Clin Dent; 2019 Nov; 10(4):e12443. PubMed ID: 31325233
[TBL] [Abstract][Full Text] [Related]
24. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.
Ranjitham PS; Kuzhali S; Sumathy MP; Gnandeepam S
Indian J Dent Res; 2023 Oct; 34(4):417-421. PubMed ID: 38739824
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
27. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
29. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
31. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
32. Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study.
Pandiar D; Aswani E; Krishnan RP
Head Neck Pathol; 2023 Dec; 17(4):932-939. PubMed ID: 37843734
[TBL] [Abstract][Full Text] [Related]
33. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
34. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of extracellular matrix changes among oral submucous fibrosis and oral squamous cell carcinoma patients of Malwa region of Punjab using special histochemical stains: An insight into cancerous transformation.
Gandhi P; Singh HP; Thippeswamy HS; Sodhi SPS; Kaur M; Laskar N
J Oral Maxillofac Pathol; 2023; 27(3):600. PubMed ID: 38033958
[TBL] [Abstract][Full Text] [Related]
36. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
[TBL] [Abstract][Full Text] [Related]
37. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study.
Kazmi A; Abbas Z; Saleem Z; Haider S; Farooqui WA; Ahmed S
BMJ Open; 2022 Dec; 12(12):e060738. PubMed ID: 36523229
[TBL] [Abstract][Full Text] [Related]
38. Mutation Analysis of the Dimer Forming Domain of the Caspase 8 Gene in Oral Submucous Fibrosis and Squamous Cell Carcinomas.
Menon U; V P; Raghuram PH; Kannan K; Govindarajan GV; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(11):4589-92. PubMed ID: 26107208
[TBL] [Abstract][Full Text] [Related]
39. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without.
Chaturvedi P; Malik A; Nair D; Nair S; Mishra A; Garg A; Vaishampayan S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):225-230. PubMed ID: 28606826
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis.
Vittal K; Pandian SS; Joseph LD; Raj SG
Indian J Dent Res; 2018; 29(2):171-175. PubMed ID: 29652009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
